Author Archives: donttradeourlivesaway

Statement by India on Non-Violation and Situation complaints in TRIPS Council meeting

October 2014 India would like to thank the chair for initiating the discussion on non-violation and other situation complaints under the TRIPS Agreement today. India associates itself with the statements made by Venezuela and Brazil which raise fundamental concerns on … Continue reading

Posted in TRIPS | Leave a comment

A very interesting article in Huffington Post about US pressure vis-a-vis India’s patent regime

Obama Has Been Fighting Doctors Without Borders For Years Source: Huffington Post 30 Oct 2014 WASHINGTON — It’s a little unusual to see the Obama administration singing the praises of Doctors Without Borders, the Nobel Peace Prize-winning nonprofit that is … Continue reading

Posted in access to medicines, Drug Pricing, Indian Patent Law, IP Rights, patent, US pressure on India | Leave a comment

Cipla asks government to revoke five patents held by Novartis

Source: Economic Times 30 Oct 2014 NEW DELHI: Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez and launched its generic version of indacaterol at a fifth of … Continue reading

Posted in access to medicines, Generic drug, IP Rights, patent, Patent Opposition | Tagged , , | Leave a comment

From think tank to trade reports – IP on the boil, again

Source: Business Line MUMBAI, OCT. 26:   Close to 10 years after the Indian Patents Act was amended in January 2005, discussions around intellectual property are on the boil again. Last week, the Government set up a think tank to draft … Continue reading

Posted in access to medicines, FDI, Intellectual Property, IP Rights, IPR policy, Out of Cycle Review (OCR), patent, Sec 3 (d), US pressure on India, USTR 301 report | Tagged | Leave a comment

Govt sets up think-tank to fine-tune IPR policy

Source: Business Line NEW DELHI, OCT 24:   The Government has constituted an Intellectual Property Rights (IPR) think-tank to help draft a new National IPR Policy and to advice it on issues related to intellectual property. The think-tank, headed by Justice … Continue reading

Posted in FTAs, IP Rights, IPR policy | Tagged , , , , | Leave a comment

Modi’s chief economic adviser Arvind Subramanian had opposed India on IPR till recently

Source: Times of India NEW DELHI: The man who has been appointed the chief economic adviser to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organization. He … Continue reading

Posted in Intellectual Property, Out of Cycle Review (OCR), patent, Patent Term Extension, Right to Health, Sec 3 (d), Special 301 report, TRIPS, US pressure on India, WTO | Tagged | Leave a comment

US pharma gets a booster shot

Source: Business Line Thanks to the India-US Intellectual Property Working Group. Here’s how — and why this is bad news for India’s poor Prime Minister Narendra Modi’s first official visit to the US included several meetings with industry representatives and … Continue reading

Posted in access to medicines, BRICS, Compulsory Licensing, Drug Pricing, FDI, Generic drug, Intellectual Property, IP Rights, IPR policy, Patent examination system, Patent Term Extension, R&D, US pressure on India, USTR 301 report, WTO | Tagged , , | Leave a comment